Skip to main content Accessibility help
×
Home

C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma

  • F Nassiri (a1), Y Mamatjan (a1), S Suppiah (a1), J Badhiwala (a1), S Mansouri (a1), S Karimi (a1), O Saarela (a1), L Poisson (a2), H Ng (a3), H Noushmehr (a2), P Harter (a4), P Baumgarten (a4), M Weller (a5), M Preusser (a6), C Mende (a7), F Sahm (a7), A von Deimling (a7), K Aldape (a8) and G Zadeh (a1)...

Abstract

Background: Challenges in predicting risk of recurrence for individual patients with meningioma limits appropriate selection of patients who may benefit from adjuvant radiation therapy to delay recurrence. Here, we aimed to develop and validate a combined clinicomolecular predictor of early recurrence for individual patients with meningiomas. Methods: A methylation-based predictor of 5-year recurrence-free-survival (RFS) was developed using DNA-methylation profiles from a training cohort of 228 patients. Model performance was compared to a standard-of-care histological-based model using three independent cohorts (N=54 ;N=140; N=64 patients). Subsequently, a nomogram that integrated the methylome-based predictor with prognostic clinical factors was developed and validated. Results: The methylome-based predictor of 5-year RFS performed favorably compared to a grade-based predictor when tested using the three validation cohorts (ΔAUC=0.10, 95%CI 0.03 – 0.018) and was independently associated with RFS on multivariable Cox regression analysis (HR=3.6, 95%CI 1.8–7.2, P<0.001). A nomogram combining the methylome-predictor with clinical factors demonstrated greater discrimination for recurrence than a nomogram using clinical factors alone (ΔAUC=0.25, 95%CI 0.22–0.27) and resulted in two risk groups with distinct recurrence patterns (HR=7.7, 95%CI 5.3–11.1, P<0.001) and clinical implications. Conclusions: Our validated models provide important novel prognostic information that could be used to individualize decisions regarding post-operative therapeutic interventions in meningioma.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma
      Available formats
      ×

Copyright

C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma

  • F Nassiri (a1), Y Mamatjan (a1), S Suppiah (a1), J Badhiwala (a1), S Mansouri (a1), S Karimi (a1), O Saarela (a1), L Poisson (a2), H Ng (a3), H Noushmehr (a2), P Harter (a4), P Baumgarten (a4), M Weller (a5), M Preusser (a6), C Mende (a7), F Sahm (a7), A von Deimling (a7), K Aldape (a8) and G Zadeh (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.